Top Story

FDA approves treatment for liver cancer with high alpha-fetoprotein

May 13, 2019
FDA News

FDA approves Cyramza for hepatocellular carcinoma

May 11, 2019
The FDA approved ramucirumab as single-agent therapy for certain patients with hepatocellular carcinoma. The approval applies to use of

Can-Fite moves forward with advanced liver cancer therapy

May 6, 2019
The FDA granted both orphan drug designation and fast track status to Namodenoson, an advanced liver cancer therapy candidate from Can-Fite BioPharma, according to a…

Milciclib safe for advanced HCC in patients resistant to Nexavar

April 26, 2019
Tiziana Life Sciences announced that treatment with milciclib for advanced hepatocellular carcinoma did not correlate with unexpected signs or signals of toxicity based…
More Headlines »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: AASLD Industry Colloquium brings together leaders in industry, academia, regulation

January 19, 2018
More »